Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.74. Nemus Bioscience shares last traded at $0.72, with a volume of 79,485 shares.
Nemus Bioscience Trading Up 5.2%
The company has a market cap of $105.64 million, a price-to-earnings ratio of -8.77 and a beta of -0.04.
Nemus Bioscience Company Profile
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Featured Articles
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
